CEO Steven Mazurek Updates Shareholders on Corporate Status During Unprecedented Times

Ronetix, the Austrian supplier of high-performance JTAG/BDM/SWD devlopment tools, launched today new PEEDI support for Xilinx Zynq familiy.

The study demonstrated that selected oxygen saturation parameters were statistically improved by one dose of CX1739, but the interpretation of these results was complicated by a reduced sleep time during the night following drug treatment.

This broad method-of-use patent application covers the combined use of AMPAKINE compounds and metabotropic glutamate receptor type 5 (mGluR5) antagonists for the treatment of Fragile X syndrome.

The award will be used to test Cortex's selected proprietary High Impact AMPAKINE drug candidates in the mouse MPTP model of Parkinson's disease (PD), a well-validated model that exhibits many of the hallmarks of human Parkinson's disease and h